Clinical Trial Update: Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update on Oxmorphone Extended Release for chronic non-malignant pain reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Oxmorphone Extended Release (Oxmorphone extended release)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED